1. Development of an effectiveness evidence database and related evidence briefings

2. Outline  NHS Health Scotland Evidence for Action (EfA) Team  Effectiveness evidence database  Effectiveness evidence briefings  Thoughts and feedback

3. NHS Health Scotland Corporate Structure

4. EfA – Public Health Sciences

5. EfA’s key areas  Getting the evidence (e.g. gathering, synthesising and overviewing)  Communicating the evidence (e.g. providing evidence briefings/updates)  Using the evidence by contributing to collaborative decision making and modelling (e.g. policy and programme development and delivery, logic model development)  Getting new evidence by contributing to the production/management of evidence strategies and/or commissioning new evidence

6. EfA’s key challenge  Our ‘customers’ frequently require evidence:  synthesised and summarised into short, easy to understand statements  is trusted or of a known quality  quickly  This combination is often very challenging

7. EfA’s approach  Initially review only ‘highly processed’ evidence  evidence drawn from sources that have already been critically appraised using robust, transparent procedures (e.g. recommendations and conclusions from SIGN Guidelines, NICE PH Guidance, WHO Guidance, Cochrane Reviews, positively appraised DARE systematic reviews)  Review less highly processed evidence but where possible provide caveats as to its use

8. Key outputs and ‘customers’ Outputs  ‘Off the peg’ (e.g. Scottish Commentaries/Perspectives/ Briefings on NICE Guidance)  ‘Bespoke’ (e.g. various briefings, evidence summaries) Customers  Various SG policy leads  Colleagues in Health Scotland (PDD and PEA)  Little direct support to Boards and other partners

9. Effectiveness evidence database  Many useful databases already in existence  However, these are often very narrow (e.g. DARE) or very broad (e.g. NHS Evidence)  Aim of the database is to provide the public health workforce with highly accessible, up-to- date effectiveness evidence, drawn from sources of a known and trusted quality across a range of contemporary health improvement topics

13. Future?  Following discussion with key stakeholders amend database with intention of going live next year  Develop the capacity to undertake deep/full- text searching of the reviews/guidance, to enable users to access specific parts of reviews/guidance (e.g. evidence statements and recommendations)  Addition of new topics

14. HS Evidence Briefings  Series of briefings produced for each HI topic  Each topic split into a series of sub-topics  Separate briefings produced for each sub-topic  Briefings summarise the highly processed evidence  Examples given of what local implementation would look like  Briefings updated every 3 months  Draft briefing produced for alcohol  Test these out with key stakeholders (as part of HI Portal testing)  Phase roll-out, starting with selected topics next year

15. Alcohol reduced availability

17. Future? Would like to expand briefings to include:  Contextual information  Effect sizes  Cost-effectiveness data  Evidence from less highly-processed sources  Qualitative evidence  New topics/subjects

18. Contact Details Dr Matthew Lowther, Principal Public Health Adviser, NHS Health Scotland Tel: 0141 354 2939 Matthew.lowther@nhs.net www.healthscotland.com